Why I’d buy FTSE 100 stock Smurfit Kappa Group plc before BTG plc today

I think the growth story at BTG plc (LON: BTG) looks stale while Smurfit Kappa Group plc (LON:SKG) shines.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I view mid-cap healthcare company BTG (LSE: BTG) as a growth company because it doesn’t pay investors a dividend. If all the incoming cash flow is being ploughed back into the business to build it up and grow earnings – as a ‘no dividend’ policy suggests – we can only judge the stock’s value based on the earnings growth and share-price appreciation it produces.

A disappointing outcome

Earnings growth stuttered along over the past four years but annual double-digit percentage increases just haven’t been a consistent feature, and the market has compressed the firm’s valuation. The share-price chart looks like the stock moved sideways. But in January 2015 the share price stood at 812p and today’s trading update sent it down more than 17% to stand around 548p as I write – a disappointing outcome for investors who have been faithful to the BTG story.

Today’s news is that the trading year to March 2018 produced revenue “in line with expectations.”  However, to many, the big hope is that the firm’s varicose vein treatment Varithena will take off in a big way in the US to produce more of those double-digit earnings gains that we all hanker for. Getting the stuff moving over there has been a frustrating experience for the firm and today we learned that growth in Varithena sales was offset by lower sales of the PneumRx Coils.” So even as Varithena starts to gain traction, its impact on the firm’s results is being neutralised by weakness in other products. After such a long wait and such high expectations, I’m not surprised the market has reacted badly.

BTG is taking an impairment charge of £150m as it marks down the fair value of PneumRx Coils and said “renewed physician interest” means it hopes to have “a better understanding of physician ordering and reordering patterns” for Varithena by the end of 2018 – yet more patience required from long-suffering shareholders.

Grinding on

City analysts predict earnings will lift 10% for the current year to March 2019 and 15% the year after that. Meanwhile, the forward price-to-earnings (P/E) ratio stands at about 15, which looks fair. But I’ve lost my enthusiasm for the stock.

To me, paper-based paper products provider and FTSE 100 constituent Smurfit Kappa Group (LSE: SKG) looks like a better bet. The company is the larger of the two operations and is attractive for its modest valuation, investor dividends and the defensive nature of its business. Today’s share price around 3,034p throws up a forward P/E rating just under 14 for 2019 and the forward dividend yield sits just over 2.8%. Anticipated forward earnings should cover the payment a healthy looking two-and-a-half times.

The firm grinds on making steady progress and City analysts expect earnings to grow 30% this year and 3% in 2019.

In today’s news, the firm announced that it is installing at its Interwell plant in Austria a “revolutionary new industrial-scale HP PageWide C500 digital press for corrugated printing.” The press will be installed in April to support Smurfit Kappa’s “extensive customer base” in the fast-moving consumer goods (FMCG) sector. I think the firm’s operations are embedded in an attractive sector and the stock looks interesting.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any of the shares mentioned. The Motley Fool UK has recommended BTG. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

3 things that could push the Lloyds share price to 60p and beyond

The Lloyds share price has broken through 50p. Next step 60p? And then what? Here are some thoughts on what…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

£1,000 in Rolls-Royce shares a year ago would be worth this much now

Rolls-Royce shares have posted one of the best stock market gains of the past 12 months. But what might the…

Read more »

Investing Articles

Are HSBC shares a FTSE bargain? Here’s what the charts say!

There are plenty of dirt-cheap FTSE 100 banking stocks for investors to choose from today. Our writer Royston Wild believes…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing Articles

Just released: Share Advisor’s latest ‘Hold’ recommendation [PREMIUM PICKS]

In our Share Advisor newsletter service, we provide buy, sell, and hold guidance for our universe of recommendations.

Read more »

Investing Articles

Investing £5 a day could help me build a second income of £329 a month!

This Fool explains how £5 a day, or one less takeaway coffee, could help her build a monthly second income…

Read more »